Concepedia

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

M. Commenges-Ducos, Stéphanie Piault, Aline Papaxanthos-Roche, Claude Ribes, D. Dallay, Daniel Commenges

Fertility and Sterility · 2002 · 15 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Human Estrogen Receptor β-Gene Structure, Chromosomal Localization, and Expression Pattern1

Eva Enmark, Markku Pelto‐Huikko, Kaj Grandien et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 1.1K citations

, , +15

Hormonal Dynamics at Midcycle: A Reevaluation*

J. D. Hoff, M. E. QUIGLEY, S. S. C. YEN · The Journal of Clinical Endocrinology & Metabolism · 1983 · 531 citations

, , +17

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

Lars Westergaard · Human Reproduction · 2000 · 310 citations

, , +15

A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group

Human Reproduction · 1998 · 293 citations · Full text

, , +17

Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.

B.C. Schoot, Herjan J.T. Coelingh Bennink, Bernadette Mannaerts et al. · The Journal of Clinical Endocrinology & Metabolism · 1992 · 167 citations · Full text

, , +17